Congenital cataract-causing mutation βB1-L116P is prone to amyloid fibrils aggregation and protease degradation with low structural stability

Int J Biol Macromol. 2022 Jan 15:195:475-482. doi: 10.1016/j.ijbiomac.2021.12.044. Epub 2021 Dec 10.

Abstract

Congenital cataract, a common disease with lens opacification, causes blindness in the newborn worldwide and is mainly caused by abnormal aggregation of crystallin. As the main structural protein in the mammalian lens, βB1-crystallin has an important role in the maintenance of lens transparency. Recently, the L116P mutation in βB1-CRY was found in a Chinese family with congenital nuclear cataracts, while its underlying pathogenic mechanism remains unclear. In the current study, the βB1 wild-type protein was purified, and the mutated form, βB1-L116P, was examined for examining the effect on structural stability and susceptibility against environmental stresses. Our results reveal low solubility and structural stability of βB1-L116P at physiological temperature, which markedly impaired the protein structure and the oligomerization of βB1-crystallin. Under guanidine hydrochloride-induced denaturing conditions, βB1-L116P mutation perturbed the protein unfolding process, making it prone to amyloid fibrils aggregation. More importantly, the L116P mutation increased susceptibility of βB1-crystallin against UV radiation. βB1-L116P overexpression led to the formation of more serious intracellular aggresomes under UV radiation or oxidative stress. Furthermore, the βB1-L116P mutation increased the sensitivity to the proteolysis process. These results indicate that the low structural stability, susceptibility to amyloid fibrils aggregation, and protease degradation of βB1-L116P may contribute to cataract development and associated symptoms.

Keywords: Amyloid fibrils aggregation; Congenital cataract; Protease degradation; Structural stability; βB1-crystallin mutation.

MeSH terms

  • Alleles
  • Amino Acid Substitution
  • Amyloid / metabolism*
  • Cataract / genetics
  • Cataract / pathology
  • Chemical Phenomena
  • Genetic Predisposition to Disease
  • Humans
  • Molecular Dynamics Simulation
  • Mutation*
  • Protein Aggregation, Pathological / genetics*
  • Protein Aggregation, Pathological / metabolism
  • Protein Conformation
  • Protein Stability
  • Spectrum Analysis
  • Structure-Activity Relationship
  • beta-Crystallin B Chain / chemistry*
  • beta-Crystallin B Chain / genetics*
  • beta-Crystallin B Chain / metabolism*

Substances

  • Amyloid
  • beta-Crystallin B Chain